Evaluation of the Anticancer Activity and Mechanism Studies of Glycyrrhetic Acid Derivatives toward HeLa Cells
Open Access
Abstract
In this paper, a series of glycyrrhetic acid derivatives 3a–3f were synthesized via the esterification reaction. The cytotoxicity of these compounds against five tumor cells (SGC-7901, BEL-7402, A549, HeLa and B16) and normal LO2 cells was investigated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. The results showed that compound 3a exhibited high antiproliferative activity against HeLa cells (IC50 = 11.4 ± 0.2 μM). The anticancer activity was studied through apoptosis, cloning, and scratching; the levels of the intracellular ROS, GSH, and Ca2+; and the change in the mitochondrial membrane potential, cell cycle arrest and RNA sequencing. Furthermore, the effects of compound 3a on gene expression levels and metabolic pathways in HeLa cells were investigated via transcriptomics. The experimental results showed that this compound can block the cell cycle in the S phase and inhibit cell migration by downregulating Focal adhesion kinase (FAK) expression. Moreover, the compound can reduce the intracellular glutathione (GSH) content, increase the Ca2+ level and the intracellular ROS content, and induce a decrease in the mitochondrial membrane potential, further leading to cell death. In addition, it was also found that the mechanism of compounds inducing apoptosis was related to the regulation of the expression of mitochondria-related proteins B-cell lymphoma-2 (Bcl-2), Bcl-2-Associated X (Bax), and the activation of the caspase proteins. Taken together, this work provides a help for the development of glycyrrhetinic acid compounds as potential anticancer molecules.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2020A1515010524, 21877018)
- National Natural Science Foundation of China (2020A1515010524, 21877018)
This publication has 46 references indexed in Scilit:
- Conversions at C‐30 of Glycyrrhetinic Acid and Their Impact on Antitumor ActivityArchiv der Pharmazie, 2011
- Mitochondrial ROS generation for regulation of autophagic pathways in cancerBiochemical and Biophysical Research Communications, 2011
- Selective toxicity of glycyrrhetinic acid against tumorigenic r/m HM-SFME-1 cells is potentially attributed to downregulation of glutathioneBiochimie, 2011
- Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acidEuropean Journal of Medicinal Chemistry, 2010
- Synthesis and antitumour activity of glycyrrhetinic acid derivativesBioorganic & Medicinal Chemistry, 2010
- Anti-tumor agents 255: Novel glycyrrhetinic acid–dehydrozingerone conjugates as cytotoxic agentsBioorganic & Medicinal Chemistry, 2007
- Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damageMitochondrion, 2007
- p38α MAP Kinase as a Sensor of Reactive Oxygen Species in TumorigenesisCancer Cell, 2007
- The Pathophysiology of Mitochondrial Cell DeathScience, 2004
- Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome cCell, 1996